Patents by Inventor Russell U. Nesbitt

Russell U. Nesbitt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transdermal matrix system
    Patent number: 4789547
    Abstract: A composition for the transmembranal, including transdermal, administration of a pharmaceutical preparation comprising cross-linked carboxymethylcellulose, an alcohol soluble poly (2-hydroxyethyl) methacrylate), a permeation enhancer, such as a mixture of linoleic acid and propylene glycol, and a biologically active material, as well as a device for administering the aforementioned composition to mammals, and also a method for administering transdermally to a mammal an effective amount of the aforementioned composition.
    Type: Grant
    Filed: June 17, 1987
    Date of Patent: December 6, 1988
    Assignee: Warner-Lambert Company
    Inventors: Suk-Zu Song, Surendra C. Mehta, Zahra A. Rashidbaigi, Russell U. Nesbitt, Mahdi B. Fawzi
  • Coated dosage forms
    Patent number: 4786508
    Abstract: Aqueous solutions of certain cationic (meth)acrylic ester copolymers can be used to coat dosage forms to taste- and odor-mask bio-active agents therein. Pellets are highly preferred dosage forms.
    Type: Grant
    Filed: May 30, 1986
    Date of Patent: November 22, 1988
    Assignee: Warner-Lambert Company
    Inventors: Isaac Ghebre-Sellassie, Robert Gordon, Maryann Mench, Russell U. Nesbitt, Jr., Mary E. Trapold
  • Thrombin preparations
    Patent number: 4696812
    Abstract: Thrombin solutions can be rendered storage stable using stabilizing quantities of an anti-autolytic buffer in combination with low levels of saline and glycerol to prevent denaturation.
    Type: Grant
    Filed: October 28, 1985
    Date of Patent: September 29, 1987
    Assignee: Warner-Lambert Company
    Inventors: Steven B. Silbering, Russell U. Nesbitt, Mahdi B. Fawzi
  • Transdermal formulations
    Patent number: 4666926
    Abstract: 3-phenoxypyridine and its salts are useful in transdermal formulations as cognition activators.
    Type: Grant
    Filed: February 27, 1986
    Date of Patent: May 19, 1987
    Assignee: Warner-Lambert Company
    Inventors: Majid Mahjour, Russell U. Nesbitt, Jr., Mahdi B. Fawzi, Bernadette Tedeschi
  • Procaterol stabilization
    Patent number: 4616022
    Abstract: Procaterol, and pharmaceutically active forms thereof, can be rendered resistant to attack by moisture and air via reaction with certain stabilizing reagents.
    Type: Grant
    Filed: August 17, 1984
    Date of Patent: October 7, 1986
    Assignee: Warner-Lambert Company
    Inventors: Isaac Ghebre-Sellassie, Russell U. Nesbitt, Jr.
  • Process for treating dosage forms
    Patent number: 4600645
    Abstract: The problems of tackiness and long curing times usually associated with the treatment of dosage forms are overcome via the use of a new curing process. That process involves: (1) coating a drug with a sustained release formulation, (2) immediately coating with a water-soluble overcoat, (3) drying, and (4) recovering the coated dosage form.
    Type: Grant
    Filed: January 31, 1985
    Date of Patent: July 15, 1986
    Assignee: Warner-Lambert Company
    Inventors: Isaac Ghebre-Sellassie, Robert H. Gordon, Michael R. Harris, Russell U. Nesbitt, Jr.